TheEdgeResearch
Home / Stocks / CGTL

Creative Global Technology Holdings Limited Ordinary Shares (CGTL)

NASDAQ Industrials Industrial - Distribution
$3.75 ▼ -3.60%
Market Cap
$5.9M
Sector
Industrials
Industry
Industrial - Distribution
Beta
0.35
52-Wk Range
2.28-96
CEO
Hei Tung Siu
Country
HK
Currency
USD

Creative Global Technology Holdings Limited Ordinary Shares operates in the Industrial - Distribution industry of the Industrials sector, headquartered in Kwun Tong, HK. The stock last traded at $3.75, down 3.60% on the session, giving a market capitalisation of $5.9M. On trailing twelve-month figures it carries a trailing P/E of -3.03, a net margin of -63.4%. Its beta of 0.35 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.03
Price / Sales
2.17
Price / Book
2.77
EV / EBITDA
-3.18
Gross margin
10.8%
Operating margin
-68.2%
Net margin
-63.4%
Return on equity
Debt / equity
0.00
Current ratio
72.54
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
12
IPO date
2024-11-26
Headquarters
Kwun Tong, HK
About Creative Global Technology Holdings Limited Ordinary Shares

Creative Global Technology Holdings Limited (CGTL), an investment holding entity based in Hong Kong, primarily focuses on the acquisition and redistribution of second-hand consumer electronics. Its offerings encompass smartphones, tablets, and laptops. The company's operations are channelled through its 2016-founded subsidiary, Creative Global Technology (Hong Kong) Limited (CGTHK). CGTHK procures these pre-owned devices from vendors in the United States, Japan, and other industrialized nations, then supplies them to wholesale clients throughout Southeast Asia and beyond.

Comparable companies

Creative Global Technology Holdings Limited Ordinary Shares is most often compared with the following Industrials names:

ATERAZIBYAHCENNDSSIPWREBNUCARYJYYGH
More research on CGTL
CGTL technical analysis CGTL TheEdge Score Compare against peers
Open full interactive analysis & DCF →